In a white-hot market with major players anxious to compete now
•Top players all above $5B market caps ($20B global market)
•High Margin, High ASP, High Volume product lines
•Strategics all support “tools in toolbox” and seeking solutions
Devices that will 100% compete with Inari and Penumbra
•Proven mechanisms of action (50+ years)
•Versatility
•Economics
A US 510(k) cleared device (7F) used in 25+ patients
•Safety & Efficacy
•Excellent IP (granted, protected)
A platform into future indications
•Pulmonary Embolism
•Dialysis
Best in class team, advisors, and partners (therapeutic experts in R&D, Sales, Marketing, and Manufacturing)